Cargando…
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union
Gene therapy, cell therapy, and tissue engineering have the potential to revolutionize the treatment of disease and injury. Attaining marketing authorization for such advanced therapy medicinal products (ATMPs) requires a rigorous scientific evaluation by the European Medicines Agency—authorization...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746151/ https://www.ncbi.nlm.nih.gov/pubmed/29280318 http://dx.doi.org/10.1002/sctm.17-0003 |